Quantum Medical Transport, Inc.
Quantum Medical Transport, Inc. Fundamental Analysis
Quantum Medical Transport, Inc. (DRWN) shows moderate financial fundamentals with a PE ratio of 0.36, profit margin of 17.01%, and ROE of -1.05%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 106.7/100 based on profitability, valuation, growth, and balance sheet metrics. The A grade reflects excellent fundamentals and strong overall stability.
Fundamental Health Score
We analyze DRWN's fundamental strength across five key dimensions:
Efficiency Score
ExcellentDRWN demonstrates superior asset utilization.
Valuation Score
ExcellentDRWN trades at attractive valuation levels.
Growth Score
WeakDRWN faces weak or negative growth trends.
Financial Health Score
ModerateDRWN shows balanced financial health with some risks.
Profitability Score
ModerateDRWN maintains healthy but balanced margins.
Key Financial Metrics
Is DRWN Expensive or Cheap?
P/E Ratio
DRWN trades at 0.36 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, DRWN's PEG of 0.00 indicates potential undervaluation.
Price to Book
The market values Quantum Medical Transport, Inc. at -0.39 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 0.00 times EBITDA. This is generally considered low.
How Well Does DRWN Make Money?
Net Profit Margin
For every $100 in sales, Quantum Medical Transport, Inc. keeps $17.01 as profit after all expenses.
Operating Margin
Core operations generate 17.01 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $-1.05 in profit for every $100 of shareholder equity.
ROA
Quantum Medical Transport, Inc. generates $17.16 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Quantum Medical Transport, Inc. generates limited operating cash flow of $3.11K, signaling weaker underlying cash strength.
Free Cash Flow
Quantum Medical Transport, Inc. generates weak or negative free cash flow of $3.11K, restricting financial flexibility.
FCF Per Share
Each share generates $0.00 in free cash annually.
FCF Yield
DRWN converts 0.04% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
0.36
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.004
vs 25 benchmark
P/B Ratio
Price to book value ratio
-0.39
vs 25 benchmark
P/S Ratio
Price to sales ratio
18.30
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
-5.34
vs 25 benchmark
Current Ratio
Current assets to current liabilities
0.04
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
-0.01
vs 25 benchmark
ROA
Return on assets percentage
0.17
vs 25 benchmark
ROCE
Return on capital employed
-1.08
vs 25 benchmark
How DRWN Stacks Against Its Sector Peers
| Metric | DRWN Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 0.36 | 27.91 | Better (Cheaper) |
| ROE | -1.05% | 687.00% | Weak |
| Net Margin | 17.01% | -45285.00% (disorted) | Strong |
| Debt/Equity | -5.34 | 0.33 | Strong (Low Leverage) |
| Current Ratio | 0.04 | 2795.76 | Weak Liquidity |
| ROA | 17.16% | -13557.00% (disorted) | Strong |
DRWN outperforms its industry in 4 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Quantum Medical Transport, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Defensive, Growth, Innovation
EPS CAGR
N/A
Industry Style: Defensive, Growth, Innovation
FCF CAGR
N/A
Industry Style: Defensive, Growth, Innovation